Viewing Study NCT00813293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-24 @ 10:51 AM
Study NCT ID: NCT00813293
Status: COMPLETED
Last Update Posted: 2023-06-13
First Post: 2008-12-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Sponsor: Beth Israel Deaconess Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatocellular Cancer View
None HCC View
None Liver Cancer View
None radiofrequency ablation View
None RFA View
None sorafenib View
None nexavaar View
None liver directed therapy View
None interventional radiology View